FARINEA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 117
EU - Europa 70
AS - Asia 49
Totale 236
Nazione #
US - Stati Uniti d'America 117
SG - Singapore 40
IT - Italia 39
IE - Irlanda 8
ES - Italia 5
SE - Svezia 5
ID - Indonesia 4
NL - Olanda 3
DE - Germania 2
FI - Finlandia 2
GB - Regno Unito 2
HK - Hong Kong 2
IN - India 2
CN - Cina 1
FR - Francia 1
LU - Lussemburgo 1
LV - Lettonia 1
PT - Portogallo 1
Totale 236
Città #
Santa Clara 42
Singapore 36
Chandler 18
Turin 16
Dublin 8
Columbus 7
Nyköping 5
Rome 5
Jakarta 4
Genoa 3
Madrid 3
Croydon 2
Hyderabad 2
Lappeenranta 2
Maastricht 2
Nules 2
Ashburn 1
Berlin 1
Bologna 1
Calci 1
Lisbon 1
Luxembourg 1
Medford 1
Modena 1
Newark 1
Princeton 1
Riga 1
Salzano 1
San Diego 1
Totale 170
Nome #
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors 55
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 47
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 37
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer harboring HRR mutations: interim results of the UNITO-001 phase 2 prospective trial 29
The role of germline mutations in thoracic malignancies: between myth and reality 29
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer 23
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis 17
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives 13
Totale 250
Categoria #
all - tutte 1.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 1 1 6 2
2022/202354 6 6 1 4 5 10 2 11 6 0 3 0
2023/202458 10 7 2 4 0 3 3 2 7 7 6 7
2024/2025128 1 22 12 19 56 18 0 0 0 0 0 0
Totale 250